Jun 5 |
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383
|
Jun 5 |
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
|
Jun 5 |
The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme
|
Jun 5 |
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
|
Jun 4 |
3 Dividend Stocks You May Want To Double Down On
|
Jun 4 |
Top Stocks to Buy in June
|
Jun 4 |
RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis
|
Jun 4 |
Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50
|
Jun 3 |
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
|
Jun 3 |
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
|